Vitiligo is a world problem so the market is huge, even if Recell GO treats 10% of the market that's billions of dollars at $6,500 a treatment..... Like every new indication they get approved and surgeons use for different scenarios and problems and also patients request it further growing revenues.
The last presentation gives and idea of future uses for cancer, trauma, burns, Vitiligo etc etc look at page 12 of the investor presentation dated 28/02/2024 and the Recell Go market is huge and growing
RECELL: Market Sizing for Burn and Full-Thickness Skin DefectsP 12Traumatic Wounds• Degloving (Open Wounds) 99,000• Crush 2,000• Abrasion 5,000• Laceration 10,000• Puncture 2,000Surgical Wounds• Necrotizing Fasciitis 2,000• Amputation 6,000• Fasciotomy 1,000Traumatic Wounds•Gun Shot Wounds 1,500•Traumatic Hematoma 2,500Surgical Excision – Cancer•Cancer Excision 136,000Market SizePrior to FDA Approval1Total market opportunity of traumatic, surgical, cancer excision & chronic wounds~400,000 annual FTSD eligible proceduresPLUS ~35,000 annual burn eligible proceduresAdditional Market Opportunitywith FDA Approved Expanded Indication of FTSD1Surgical Wounds•Laparotomy 1,000•Abdominoplasty Dehiscence 1,000•Hidradenitis Suppurativa 1,500Chronic Wounds•DFU 21,000•VLU 42,000•Non - Pressure Ulcers 51,000•Pressure Ulcers 14,000~127,000 Annual Eligible Procedures> 271,500 Annual Eligible Procedures(1) Market size derived from third-party claims reports and internal analysis based on skin graft CPT codes tied to diagnosis code of specified wound types.
Expand
